MARKET

CLSN

CLSN

Celsion
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8500
-0.0500
-5.56%
After Hours: 0.8450 -0.005 -0.59% 17:04 03/27 EDT
OPEN
0.9300
PREV CLOSE
0.9000
HIGH
0.9765
LOW
0.8500
VOLUME
150.26K
TURNOVER
--
52 WEEK HIGH
2.530
52 WEEK LOW
0.6865
MARKET CAP
24.87M
P/E (TTM)
-2.3703
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CLSN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CLSN stock price target is 7.33 with a high estimate of 9.00 and a low estimate of 4.000.

EPS

CLSN News

More
  • Edited Transcript of CLSN earnings conference call or presentation 26-Mar-20 3:00pm GMT
  • Thomson Reuters StreetEvents · 1d ago
  • Celsion Corporation's (CLSN) CEO Michael Tardugno on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 1d ago
  • Celsion Corp. to Host Earnings Call
  • ACCESSWIRE · 1d ago
  • Celsions OVATION 1 Study with GEN-1 in Ovarian Cancer Shows Strong Progression-Free Survival Treatment Effect Utilizing Medidata Synthetic Control Arm
  • GlobeNewswire · 1d ago

Industry

Biotechnology & Medical Research
-2.43%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About CLSN

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).
More

Webull offers kinds of Celsion Corporation stock information, including NASDAQ:CLSN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLSN stock news, and many more online research tools to help you make informed decisions.